INDICATION AND USAGE

 Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with ⚫metastatic castration-sensitive prostate cancer ⚫ non-metastatic castration-resistant prostate cancer.

DOSAGE AND ADMINISTRATION The recommended dose of Apalutamide is 240 mg (four 60 mg tablets) administered orally once daily. Swallow the tablets whole. Apalutamide can be taken with or without food. Patients should also receive a gonadotropin-releasing hormone (GnRH) analog concurrently or should have had a bilateral orchiectomy.

FIND A PRODUCT